VR Logo

Sterling Biotech Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

38 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of gelatine and its derivatives, resinoids, glues, prepared adhesives, including rubber-based glues and adhesives

Incorporated: 1985

Chairman: --

Managing Director: Nitin Sandesara

Group: Sandesara

Listing: NSE: STERLINBIO, BSE: 512299

Headquarters: Mumbai, Maharashtra

Website: www.sterlinggelatin.com/www.sterlingbiotech.in

Key Facts

Market cap: R 20.96 Cr

Revenue (TTM): R 352.33 Cr

Earnings (TTM): R -1,005.39 Cr

Cash: R 13.28 Cr

Total Debt: R 7,492.69 Cr

Promoters' ownership: 24.64%

Liquidity:

52 Week range: R 0.60 - 5.55

Face value: R1.00

Shares outstanding: 27,21,70,388

Stock Performance

Time Period Sterling Biotech S&P BSE Small Cap* S&P BSE Healthcare*
YTD--8.375.06
1 month--10.925.31
3 months--12.439.47
1 Year--4.360.79
3 Years--4.71-1.86
5 Years--5.48-1.87
10 Years--5.5311.24
As on 27-Jan-2020 *As on 24-Jan-2020
Year Sterling Biotech S&P BSE Small Cap S&P BSE Healthcare
20179.8659.640.49
2016-52.351.77-12.88
20150.686.7615.06
2014-19.1969.2447.43
201364.42-11.2322.55
2012-75.9832.7638.28
2011-79.27-42.61-12.83